Edition:
United Kingdom

Aratana Therapeutics Inc (PETX.OQ)

PETX.OQ on NASDAQ Stock Exchange Global Market

5.25USD
16 Aug 2018
Change (% chg)

-- (--)
Prev Close
$5.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
74,757
52-wk High
$7.28
52-wk Low
$3.68

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.14 December 17 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 3
(2) OUTPERFORM 4 4 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.67 1.67 1.57

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 6 6.08 8.40 4.96 12.00
Quarter Ending Dec-18 6 15.04 22.90 7.10 13.55
Year Ending Dec-18 6 28.45 38.06 20.52 44.20
Year Ending Dec-19 7 47.01 53.20 36.30 66.79
Earnings (per share)
Quarter Ending Sep-18 5 -0.14 -0.11 -0.20 -0.14
Quarter Ending Dec-18 5 -0.04 0.16 -0.14 -0.05
Year Ending Dec-18 6 -0.50 -0.29 -0.61 -0.41
Year Ending Dec-19 7 -0.26 -0.09 -0.52 -0.20

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 5.06 4.91 0.15 2.99
Quarter Ending Mar-18 5.28 4.04 1.23 23.39
Quarter Ending Dec-17 6.82 10.46 3.64 53.33
Quarter Ending Sep-17 6.47 6.16 0.31 4.75
Quarter Ending Jun-17 4.72 5.16 0.43 9.16

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 6.08 6.14 6.24 6.24 12.00
Quarter Ending Dec-18 15.04 16.12 15.82 15.82 13.55
Year Ending Dec-18 28.45 29.87 33.14 33.14 44.20
Year Ending Dec-19 47.01 47.01 46.38 46.38 66.79

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 2 3
Quarter Ending Dec-18 0 0 1 4
Year Ending Dec-18 0 0 2 4
Year Ending Dec-19 0 0 2 3
Earnings